Analyst Ratings for Supernus Pharmaceuticals Inc. (SUPN)

Updated: 2017-07-27

An average rating of Overweight has been given to Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) by analysts covering the stock. SUPN had previously received a consensus rating of Buy a month ago.

Of the 7 analysts covering the stock, 5 gave it a buy rating, 0 issued an overweight rating, 2 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Many analysts weighed in on price targets for SUPN. The highest price target was 51, implying a possible profit of 24.09 percent. The lowest price target was 40, implying a possible loss of -2.68 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -7.56 percent. The average change in earnings estimates over the last 90 days is -23.79 percent. Over the past 30 days, FY earnings estimates have also changed downwards by -7.71 percent. If we look at the last 90 days instead, we find a net average change of -21.32 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 3 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 3 analysts that revised their FY estimates downwards.

SUPN has an estimated earnings growth rate of -46.43 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of SUPN is -0.48.

In the last 52-weeks, SUPN has achieved a high of 44.95 and a low of 17.25. Currently the stock is 138.26 percent higher than its low, and 8.57 percent lower than its 52-week high. SUPN has a price/earnings ratio of 22.48. Investors typically compare the P/E ratio to a company's peers in the industry. The SUPN value stock report compares SUPN to some of its peers using value stock charts. The stock has a market capitalization of $2.12 billion. SUPN's next earnings release will be on 0000-00-00, which is days away.